Clarithromycin Price Index & Market Trends: Key Factors Influencing Global Prices

Clarithromycin Prices – Market Trends, Index, Analysis, Demand Outlook and Forecast (Q3 2025)

The global Clarithromycin market experienced mild downward pressure during the Quarter Ending September 2025 (Q3 2025) as pharmaceutical supply chains normalized, inventories increased across key regions, and tariff-related uncertainties limited aggressive procurement. Weak offtake from downstream formulation industries and oversupply conditions in major manufacturing hubs contributed to modest price declines across North America, APAC, and Europe.

This comprehensive analysis covers Clarithromycin Prices, Price Index movements, regional pricing trends, supply–demand dynamics, and the market outlook for the coming quarter.

Overview of Clarithromycin Prices in Q3 2025

Across all major regions, the Clarithromycin market displayed a synchronized decline, though the extent of price softening remained relatively marginal. Manufacturers in China, India, and Europe reported sufficient operating rates, while end-users—primarily pharmaceutical formulation companies—maintained conservative purchase volumes due to steady but unspectacular consumption trends in the antibiotic segment.

The global oversupply situation, combined with tapered buying activities, led to muted price performance. However, cost support from feedstock materials and stable production economics prevented sharper declines.

Get Real time Prices for Clarithromycin : https://www.chemanalyst.com/Pricing-data/clarithromycin-1387

North America Clarithromycin Prices (USA)

Price Index and Quarterly Movement

In North America, the Clarithromycin Price Index fell by 0.33% quarter-over-quarter in Q3 2025. This mild decline reflects a combination of global oversupply, higher import arrivals, and the broader uncertainty surrounding tariff policies on pharmaceutical intermediates and APIs.

Formulation companies in the United States adopted a reserved procurement strategy throughout the quarter, primarily due to stable consumption in both hospital and retail channels. Vaccination-related surges in certain antibiotic categories had cooled, resulting in normalizing demand patterns.

Average Prices

The average Clarithromycin price in the USA for Q3 2025 stood at:

USD 205,826.67/MT (CFR Los Angeles)

This price level underscores abundant availability and limited cost pressure on importers, who continued to capitalize on competitive offers from Asian suppliers.

Market Dynamics in North America

Key factors influencing prices:

Oversupply from global producers led to competitive offers into the US market.

Tariff and trade policy uncertainty, especially regarding pharmaceutical imports from Asia, made buyers cautious.

High inventory levels at distributor and importer levels prevented aggressive restocking.

Moderate demand from oral solid dosage manufacturers kept consumption steady but unremarkable.

Despite the minor dip, the market avoided sharp volatility, reflecting the maturity and stability of US pharmaceutical procurement channels.

APAC Clarithromycin Prices (China)

Price Index and Regional Performance

In the Asia-Pacific region, China—one of the world’s largest antibiotic and API manufacturers—saw the Clarithromycin Price Index decline by 0.31% quarter-over-quarter in Q3 2025.

Average Prices

The average Clarithromycin price in China during the quarter was recorded at:

USD 205,730.00/MT

Prices remained under pressure due to intense competition, substantial production capacity, and inventory-driven markdowns, as suppliers attempted to clear stocks in a subdued demand environment.

Driving Factors in APAC

Several factors shaped China’s price behavior:

🌐 🔗 Track real time Clarithromycin prices and market trends on ChemAnalyst: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Clarithromycin

Overcapacity in macrolide antibiotic intermediate manufacturing, particularly among small and mid-sized producers.

Competitive pricing among suppliers, leading to aggressive export quotations.

Soft demand from major consuming regions, limiting opportunities for price recovery.

Stable raw material costs, which supported consistent production but also contributed to oversupply.

Pressure from generic manufacturers and the rebound of competitor antibiotics also contributed to a muted performance in Q3.

Europe Clarithromycin Prices (Germany)

Price Index and Quarterly Change

In Europe, particularly Germany, the Clarithromycin Price Index dipped by 0.31%, in line with global sentiment. The decline mirrored sustained oversupply, subdued formulation demand, and high pharmaceutical inventories across the continent.

Average Prices

The average Clarithromycin price in Germany for Q3 2025 was:

USD 205,833.33/MT

European importers relied heavily on contract-based procurement, while discretionary buying fell due to excessive stock levels at both distributors and manufacturing facilities.

Key Market Trends in Europe

Pharmaceutical manufacturers in the EU operated at moderate utilization levels, with consistent demand but lower-than-expected seasonal surges.

Inventory correction cycles led many buyers to delay new orders.

Weak demand in certain antibiotic therapeutic categories, affected by slower infection rates and competition from alternative products.

Ease of availability from China and India contributed to stable but slightly declining pricing.

The EU’s strong dependence on Asian suppliers amplified the impact of global oversupply conditions.

Global Clarithromycin Market: Supply, Demand, and Trade Overview

Supply Landscape

The key global suppliers of Clarithromycin continued to maintain high availability. China’s manufacturing hubs, operating with significant installed capacities, played a decisive role in shaping international pricing trends. India also maintained steady production levels, further contributing to the global surplus.

No major supply disruptions or raw material shortages were reported during Q3 2025, which helped maintain stable operation rates.

Demand Overview

Demand for Clarithromycin is typically driven by:

Treatment of bacterial respiratory tract infections

Increasing use in combination therapies

Seasonal infection trends

However, in Q3 2025, demand growth was relatively muted, as:

Infection prevalence normalized after earlier spikes.

Pharmaceutical formulators purchased cautiously due to existing stocks.

Competition from alternative antibiotics influenced procurement patterns.

Trade and Logistics

Import-export activity remained efficient, with no major logistical bottlenecks affecting supply chains. Freight rates showed mild fluctuations but did not significantly impact CFR prices.

Clarithromycin Price Trends – Comparative Regional Snapshot (Q3 2025)

The narrow band of price variation across regions highlights the integrated and highly competitive structure of the global Clarithromycin supply chain.

Factors Contributing to Price Declines in Q3 2025

Global Oversupply
Excess volumes from China, India, and EU manufacturers created downward price pressure.

Inventory Overhang
Distributors and pharmaceutical companies held higher-than-normal stocks, limiting restocking activities.

Soft Demand Growth
Seasonal demand remained below expectations, especially in Europe and North America.

Competitive Export Offers
Suppliers, particularly in China, frequently offered discounted rates to clear inventories.

Tariff-Related Caution
Uncertainty around potential changes in US import tariffs made buyers hesitant to commit to large volumes.

Clarithromycin Price Forecast (Q4 2025 and Early 2026 Outlook)

The price outlook for Clarithromycin remains stable-to-slightly bearish in the near term, with limited upward momentum due to the following factors:

1. Stable Global Supply

Manufacturers continue to operate at comfortable capacity utilization rates with no major shutdowns expected.

2. Soft Pharmaceutical Procurement

Pharmaceutical companies are likely to maintain conservative buying strategies until inventory levels normalize.

3. Flat Raw Material Costs

Feedstocks and upstream intermediates are expected to remain relatively stable in cost, offering limited cost-push support.

4. Competitive APAC Exports

China and India are likely to continue providing competitive export quotations.

5. Potential Seasonal Uptick

A mild increase in demand may occur during the winter months, but it is unlikely to dramatically change the market direction.

Forecast Summary

Q4 2025: Prices expected to remain stable with marginal fluctuations

H1 2026: Market balance expected to improve slightly, but no strong bullish trends anticipated

Risk Factors: Trade restrictions, regulatory changes, or supply disruptions could cause short-term price volatility

Conclusion

The Clarithromycin Prices market during the Quarter Ending September 2025 demonstrated mild declines across all major regions—North America, APAC, and Europe—driven primarily by global oversupply, competitive pricing, high inventory levels, and muted demand.

Despite these downward pressures, the market remained relatively stable, with no drastic price corrections. The outlook for Q4 2025 and early 2026 remains largely steady, with supply-side comfort and moderate demand likely to keep price fluctuations contained.

Stakeholders—including pharmaceutical manufacturers, traders, procurement managers, and regulatory bodies—should continue monitoring inventory trends, trade policies, and seasonal demand patterns to optimize sourcing strategies in the dynamic Clarithromycin market.

Get Real time Prices for Clarithromycin : https://www.chemanalyst.com/Pricing-data/clarithromycin-1387

About Us:

Welcome to ChemAnalyst, a next–generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as “Product Innovator of the Year 2023” and ranked among the “Top 100 Digital Procurement Solutions Companies,” we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.

Contact Us:

ChemAnalyst

GmbH - S-01, 2.floor, Subbelrather Straße,

15a Cologne, 50823, GermanyH

Call: +49-221-6505-8833

Email: [email protected]

Website: https://www.chemanalyst.com/

LinkedIn: https://www.linkedin.com/company/chemanalyst/

Facebook: https://www.facebook.com/ChemAnalysts/

Twitter: https://x.com/chemanalysts

YouTube: https://www.youtube.com/@chemanalyst

Instagram: https://www.instagram.com/chemanalyst_